ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667911 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667911; 2) Community: the network communities that were significantly associated with the response to NSC 667911; 3) Molecule: the relationships between components within communities and NSC 667911; 4) MDR: the compounds that were significantly associated with the NSC 667911.

NSC Compound Enrichment Correlation
NSC 677275 Null 0.0454469012959173 0.31994558
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0454469012959173 0.32116196
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0454469012959173 0.16391002
NSC 681239 Bortezomib 0.0454469012959173 0.20115558
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0454469012959173 0.18080388
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0454469012959173 -0.09299499
NSC 690270 ANTINEOPLASTIC-690270 0.0454469012959173 0.20377802
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.0454469012959173 0.1640852
NSC 697166 4H-1,2,4-Triazol-4-amine, 3,3'-(1,8-octanediyl)bis[5-[(4-chlorophenoxy)methyl]- N-phenyl- 0.0454469012959173 0.36266147
NSC 699779 Null 0.0454469012959173 0.18864599
Total:115  Current:110    [First] [Prev] [Next] [Last]